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Delayed-type hypersensitivity (DTH) reactions are 
initiated by sensitized T cells. Their progression is 
dependent upon the local release of various auta-
coids, including cytokines and eicosanoids, by T 
cells, infiltrating inflammatory cells, and resident 
tissue cells . 12(R)-hydroxy-5,8,14-eicosatrienoic acid 
[12(R)-HETrE], an eicosanoid produced by skin and 
cornea, possesses potent proinflammatory properties 
at picomolar concentrations including vasodilation, 
increase in membrane permeability, neutrophil che-
motaxis, and angiogenesis. Because DTH reactions 
are associated with many of these same phenomena, 
we examined the effect of 12(R)-HETrE and related 
12_hydroxyeicosanoids on the expression of DTH to 
purified protein derivative of tuberculin in sensitized 
guinea pigs. In the absence of purified protein deriv-
ative of tuberculin, none of the eicosanoids evoked 
erythema or edema after intradermal injection at 
doses up to 100 pmol. When injected together with 
purified protein derivative of tuberculin, 12(R)-hy-
droxy_5,8,10,14-eicosatetraenoic acid [12(R)-HETE], 
A rachido nic acid and its m etaboli tes are involved in the development of cutaneous inflammation and inflammatory skin diseases [1-4] . T h e skin has the necessary en zym atic machinery to produce eico-sano ids from all three pathw ays of arachidonic acid 
m e tabo lism : cyclooll.:ygen ase, lipoxygen ase , and cytochrome P45 0 
m o nooxygena ses. fu'achidonic acid metabolites derived from cy-
cloo ll..}'genase (prostaglandins E2 and D 2 ) , lipoll..')'genase [leukotrien e 
B
4
, 12(5)- and 15(S)- hydro ll.}'eicosate tracnoic acids (HETEs)], and 
cytochrome P450 m o nooll.},gen ase [1 2(R)-hydroxy-5 ,8,1 0 , 14-eico-
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but not its enantiomer 12(S)-HETE, significantly in-
hibited macroscopic expression of delayed reactivity 
(erythema) only at the highest dose tested, 10 pmol. 
In contrast, 12(R)-HETrE significantly enhanced ex-
pression of DTH at doses between 1 finol and 1 pmol 
(50% and 30% increases above control, respectively). 
Its stereoisomer, 12(S)-HETrE, did not enhance DTH 
at any tested dose, but was able to block the activ-
ity of 12(R)-HETrE when injected simultaneously . 
Enhancement or inhibition of visible skin responses 
was not associated with qualitative or quantitative 
changes in cellulal· infiltrates at the reaction site . 
12(R)-HETrE had no effect on the nonimmunologic 
inflammatory skin reaction induced by phorbol myr-
is tate acetate, suggesting selectivity toward DTH. 
We conclude that 12(R)-HETrE enhances DTH via a 
yet to be determined mechanism and that its stereo-
isomer, 12(S)-HETrE, may b e a useful antagonist 
for studying the inflammatory actions of this eico-
sanoid. Key words: lipoxygenaselcytoel,rome P450Iarac1,i-
donie acidleieosanoids. ] Invest Dermatol 104:47-51, 1995 
sate traenoic acid (1 2 (R)-HETE)] have been detected in epid ermis, 
epidermal ceJls , and skin-cell fractions o f human, guinea p ig, 
mouse, and rat [5-13] . Other ti ssu e components involved in 
cutaneous inflanll11ation, such as endothelium, neutro phils, lym-
phocytes, monocytes, and platele ts, can produce eicosan oids from 
some or all three arachidonic acid metabolic pathways, and/or h ave 
specific receptors able to respond to th ese compounds. 
Some ar achidonic acid m etabolites exert p o tent biologic activi-
ties when administe red topically o r intradermally. In tradermal 
injection of 1-100 nmol o f leukotrien e B4, 12-HETE, or 5-HETE 
induces n eutrophil infiltration and plasm a exudation and increases 
vascular penlleability in human and guinea pig skin [1 4,15]. Both 
leukotrien e B4 and 12-HETE also stimulate epidermal proliferation 
in guinea pig skin [1 6]. T h e cytochrome-P450-derived e icosano id, 
12(R)- H ETE, causes erythem a after topical administration of n a.l1o-
mole doses to human skin .§ It is also the predomin an t 12- HETE 
§ W oollard PM, Murphy GM, Cunningham FM. Camp RDR . Greaves 
MW: ProinAammatory effects of1 2(R)-hydroxy-5.8 ,l O,14-cicosatetraenoic 
acid in human skin (abstr) . Brj DemJatoI11 8:277 . 1988 . 
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enantiomer in psot:1atlc les io ns, suggesting the involve m ent of 
cytochrome P450 monooJl"ygenase m etaboli tes in skin inflammation 
[17] . 
F urther evidence for involvemen t of cytochrome-P450-derived 
arachidon ate metabol.ites ill the pathogenesis of inflammation is 
provided by several studies in human, bovine, and rabbit com eal 
epitheHum, a specialized avascul ar form of epidermis. T he corn eal 
epitheHul11 C~Ul synthesize both Sand R stereoisom ers of 12-HETE 
[18-20]. Furth e rmore, a novel eicosanoid ide ntifi ed as 12-hydroJl.'y-
5,8,14-eicosatrienoic acid (12-HETrE) is produced from eith e r 
arach.idonic acid or 12-HETE by an NADPH- dependent m echa-
nism [21 ,22J. The formation of 12-HETE and 12-HETrE is in-
creased many-fold in infl am ed rabbit corneal epithe lium, con sistent 
with an important ro le in the inflammatory process [23,24] . Indeed , 
topica l admin.istration of 12(R)-HETrE is associated with severe 
corneal inflammation in rabbits; in vitro, 12 (R)-HETrE at picom o lar 
con centrations induces vasodilation and increases vascular perme-
abiHty, neutrophil chemotaxis, and angiogenesis [21,25,26]. rts 
stereoisomer, 12(S)-HETrE, displays none of these actions. Synthe-
sis of 12-HETrE is not restricted to the corneal e pitheHum, as both 
porcine neutrophils and rat epidermal mi crosom es have been 
shown to synthesize it [13 ,27]' However, w h ether 12-HETrE plays 
any ro le in i.n1lammatory conditions of the skin is not yet known . 
Delayed-type hypersensitivity (DTH) inflammatory reactions are 
in.itiated by sensitized T cells; their progression is d ependent upon 
the local release of various autacoids including cytokines and 
e icosalloids [28-30]. Vasodilata tion, increases in m em brane p erme-
ability, early n e utrophil ch emotaxis, and late angiogenesis are 
prominen t at various tinles during the evolution of th ese inflam-
matory responses [30]. The proinflammatory actions of 12(R)-
HETrE inclUde these same activities [25,26]. Because 12(R)-
HETrE Call be formed by both epiderm.is and le ukocytes [13,27], it 
seemed reasonable to determine whether 12(R)-HETrE alld related 
12-hydroxyeicosanoids [12(S)-HETrE, 12(R)-HETE, 12(S)-HETE] 
could modulate expression of DTH. O ur results indicate that low 
femtomol doses of 12(R)-HETrE increased cu taneous delayed 
reactivity to purified protein derivative of tubercuful (PPD) , 
whereas 12(S)-HETrE and 12-HETE e n antiomers h ad no su ch 
effect. Althoug h 12(S)-HETrE had no direct effect 0 11 th e expres-
sion of DTH, it was ab le to block the enhancing effect of 
12(R)-HETrE 011 t hese reactions. 
MATERIALS AND METHODS 
Animals Male Hartley (a lbiJlo) guin ea pigs (400 ± 50 g) were obtained 
from Elm Hill Fanns (Chel.msford, MA) . Animals were housed three to four 
to a cage and given free access to food and water. 
Materials 12(R)-HETE, 12(S)-HETE. 12(R)-HETrE, and 12(S)-HETrE 
were synthesized and purified as described previously [31,32J. T he struc-
tures of the four compounds are shown in Fig 1. Purity and iden tity of each 
compound were confirmed by high perfomulI1ce liquid chromatography 
and gas chromatography/mass spectrometry. T hey were dissolved in etha-
nol to a final concentration of 0.1 !TIM and stored at - 70°C under ni trogen. 
Freund's complete adjuvant (D IFCO, Detroit, MI) and PPD (lot RT52, 
Statens Seruminstitut. Copenh;Igen, Denmark) were purchased. Heat-killed 
mixed strains of human Myeobaeler;lI/H IlIberCII/os;s were obtained from the 
Ministry of Food, f isheries, and Agri culture (Weybridge, UK). Phorbol-
12-myristate-13-acetate (PMA) was purchased from Sigma Chemical Co. 
(St. Louis, MO). It was dissolved in dimethylsulfOl.;de to a final concen-
tration of 1 111M and stored at - 70°C. 
Sensitization and Skin Testing Gu inea pigs were sensitized by injec-
tion ofl ml Freund's complete adjuvant conta ining 1 mg heat-kil led mixed 
strains of human M Illberell /os;s and were boosted repeated ly by skin testi.ng, 
as described in detaiJ [33]. Animals sensitized using thi s protocol develop a . 
stab le high degree of DTH by 10 weeks. which is maintained for at least 6 
months [3 3]. To elicit DTf-l reactions, guinea pigs received intradermal 
injections of 0.1 ml phosphate-buffered sa line (PBS) (negative control) or 
PBS containing 500 ng PPD (positive control), or 500 ng PpD together with 
10 - 5 to 102 pmol eicosano ids, or 10- 5 to 102 pmol eicosanoids alone. Each 
animal received multiple injections at discrete sites in the Aanks. Injections 
were coded and randomize d, and skin reactions were read by a single 
individual without knowledge of the solu tions' content. T lus dose of PPD 
was chosen because it e li cits DTH reactions in these animals of 12-"1 4 mm 
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Figure 1. Structures of 12-hydroxyeicosanoids: 12(R)-HETE, 12(S)-
HETE, 12(R)-HETrE, and 12(S)-HETrE. T hese molecules arc structur-
ally similar except for the absolute stereochemistry of the hydro>.:)'1 group 
and the lack ofa do uble bond between carbons 10 and 11. Designation of 
the ste reochemistry of the hydroxyl group at C-1 2 for both 12(R)-HETE 
and 12(R)-HETrE is a consequence of the nomenclature priority rules, and 
in L1ct these two metabolites have opposite absolute stereochemistries [22]. 
T he same applies fo r 12(S)-H ETE and 12(S)-HETrE. The stereoselective 
precursor/product relation between these compounds axe y~t to be eluci-
dated . However, recent evidence suggests that both 12(R)-HETE and 
12(S)-HETE can undergo oxidation to a keto intermediate and keto-
reduction to the dillydro metabolite, 12-HETrE, in porcine polymorpho-
nuclear leukocytes and corneaJ epithelial microsomes , in which product 
enan tioselectivity varies depending on the tissue [22,27,36J. 
in diameter that resolve without gross necrosis of skin or scarring. T he 
eicosanoid doses were aclueved by injecting 0.1mJ of solutions of 10- 13 M 
to 10- 6 M. Eicosanoids were diluted in PBS at 4°C, placed in syringes, and 
injected witlun 1 h after dilution. Previous analyses have indicated that no 
significant auto-oxidation occurs w;thin tins time period . 
Injection sites were examined routinely for erythema and edema at hourly 
interva ls for the first 4 h after injection for evidence of immediate and 
Arthus hypersensitivity, and at 16-18 h after injection to document 
resolution or increase in erythema and edema noted earlier. T he intensity of 
any o bserved erythema or edema during the first 4 h was graded semiquan-
titatively on a scale of 1 + to 4 +. DTH was quantitated at 24 h (time of 
maximal reaction size) by measuring the extent of erythema (to 0.1 mm) in 
two perpendicular directions with calipers. In this guinea pig model of 
DTH, reactio n crythetna and induration have the satne extent and t ilTIC 
course [28]. R eaction sizes arc reported as mean areas (mm 2 ) obtained by 
multiplyillg reaction measurements , and as mean percent of the positi ve 
control PPD reaction. DTH reactions greater tllan 10 mm2 ;Ire considered 
significant. Data from observations made using two groups of independently 
sensitized guin ea pigs were essentially identical and have been pooled. 
To determine the effect of 12-HETrE enantiomers on a nonimmunologic 
inAammatory response, nonsensitized guinea pigs received O.l-ml intrader-
ma l injections of di luent (1 0% dimethylsul foxide in PBS), diluent containing 
10 nmol PMA, or mixtu res of PMA and 12(R)- or 12(S)-HETrE. 
Histologic Examination Punch biopsies (4 111111) ofpl)D reactions were 
taken fro m ketamine-anesthetized animals, fIXed in glutaraldehyde, embed-
ded in paraffin wax, sectioned, and sta ined with Giemsa [33]. Coded 
sections were exam ined for deep and superficial derma l cellula r infil trates by 
two independent observers (E.H ., H.P.G.) [33J. Deep dermal infiltra tes 
were evaluated qualitatively on a scale of 0 to 4 (0, no infil trates; 1, minimal 
infiltrates; 2, moderate infil trates; 3, heavy infIltra tes; 4, very heavy 
infil trates and microabscesses). R esults are presented as mea n qualitative 
assessment of deep dermal in fi ltrates <lnd mean cell numbers per five oil 
fi elds of superficial-cell infiltrates . 
Data Analysis Significance of differences in meallS was determined by 
Student t test (single comparison) or ana lysis of variance and Schcfre test 
(mul tiple comparisons) [34]. 
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RESULTS 
Modulation of PPD-Elicited Delayed Erythema by 12-Hy-
droxyeicosanoids Guinea pigs were skin-tested 20 weeks afte r 
sensitization by in trademlal injection with 500 ng PPD, with or 
without 10 - 5 to 102 pmol (0 .03 pg to 30 ng) doses of 12-
hydroxye icosanoids. Intradermal injection of 12(R)-HETE, 12(S)-
HETE, 12(R)-HET rE, 12(S)-HETrE, or diluent alone e licited no 
edema or erythema at e ithe r 1-4 h o r 24 h (data not shown). After 
intradermal injection, PPD e licited no immediate o r Arthus reac-
tions of edema or erythema at 1-4 h and e licited typical erythem-
atous DTH reactions that w e re maximal at 24 h. 
No edema or e rythema was seen at 1-4 h in sites injected with 
PPD and 12-HETE enantiomers (data not shown). At 24 h ,- the 
cytochrome-P450-derived eicosano id , 12 (R)-HETE, significantly 
inhibited PPD-elicited DTH o nly at 10 pmol , the highest dose 
tested (p < 0.05), whereas the lipo),:ygenase m e tabolite 12(S)-
HETE had no eHect on PPD-e licited DTH at any tested dose (Fig 
2) . 
Minimal edem a or e rythema was seen at 2-4 h in three of24 sites 
injec ted with PPD and 12-HETrE (data not shown). At 24 h , 
the dihydro derivatives of 12-HETE displayed a potent, stereo-
specific modulation of DTH expression . 12(R)-HETrE, but not 
12(S)-HETrE, enhanced expression of PPD-elicited DTH in a 
dose-de pendent manner (Fig 3) . The dose-response plot was 
bell-sh aped: 1 fill 01 of 12(R)-HETrE ca used a 50% increase in 
PPD-e licited erythema (p < 0.01), whereas larger doses up to 1 
pmol, although capable of significantly increasing eA-pression of 
DTH, were less e ffec tive. (A dose of 1 fill01 corresponds to 10 pM; 
1 pmol corresponds to 10 nM) . Although 12(S)-HETrE did not 
affect expression of DTH whe n injected by itself, simultaneous 
injec tion of equimolar doses of it and 12(R)-HETrE completely 
blocked the enhan cing e ffect of the latter compound (Fig 3). This 
result suggests an antagonistic property of 12(S)-HETrE on th e 
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Figure 2. Effccts of 12(R)-HETE and 12(S)-HETE on PPD-clicitcd 
DTH in guinca pigs scnsitizcd 20 weeks prcviously. R esults arc 
shown as mean skin reaction (± SEM) relative to PPD (100%). Animals 
(n = 12; except 10- 2 and IOU pl11ol. n = G) were skin- tested with 500 ng 
PPO mixed with PBS or with 500 ng PPD mixed with the indicated dose of 
eicosanoid in PBS, and reactions were measured at 24 h with calipers. 
12(R)-HETE (closed sqllnms); 12(S)-HETE (o]J ell sqllnrcs). Mean PPO reac-
tion size (± SEM): 209 ± 10 1111112 . DOlled (jll e indicates the PPO response 
(100%). T here were no visible reactions after il~jection of PBS, l 2(R)-
HETE, or 12(S)-HETE alone. • Mean differs significantly frOI11 va.lue 
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Figure 3. Enhanccment ofPPD-clicited DTH by 12(R)-HETrE in 
guinca pigs scnsitized 20 wecks prcviously. Results are shown as mean 
skin rcaction (± SEM) relative to pPO. (100%). Animals (n = 11-24) were 
skin-testcd with 500 ng PPD mixed witll PBS or Witll 500 ng PPO mixed witll 
the indicated dose of eicosanoid in PBS. and reactions were measured at 24 h 
Witll calipers. 12(R)-HETrE (closed d ldes); 12(S)-HETrE (o]Jell rildes); 12(R)-
HETrE + 12(S)-HETrE (closed trinllgles). Mean PPO reaction size (± SEM): 194 
± G mm2. DOllcd lille indicates tI,C PPO response (100%). There were no visiblc 
skin rcactions after il'\iections of PBS, 12(R)-HETrE, 12(S)-HETrE. or ti,e 
combined enantiomcrs in ti,e absence ofPPD. ' Mean differs significantly from 
value obtained "vitl, PPD alone (p < 0.05, Scheffe mul tiple comparison test). 
** Mean difFers significantly fr0111 value obtaincd ,vith PPO alonc (p < 0.01, 
SchefFe multiple comparison tcst). 
PMA-Induced Delayed Erythema is Not Modulated by 12-
HETrE To determine the specificity of the modulation of mac-
roscopic DTH responses by 12(R)-HETrE, we examined the effect 
of 12-HETrE on a nonimmullo logic de layed inflammatory re-
sponse. G uin ea pigs received intradermal injections of 10 nnlOl 
PMA, PMA with 12-HETrE, or diluent alon e (Ta ble I). No 
e rythema or edema was e li cited by the diluent either at 1-4 h or at 
24 h. PMA elicited minimal eryth em a at 3 h in two of s1., animals 
and mode ra te e ryth ema at 4 h in all six animals. At 24 h , PMA 
e licited an erythe m atous response of 89 :!:: 1 111m 2 . Unlike the PPD 
response, the PMA reaction was severely edematous, and showed 
central necrosis and scattered areas of de rlll al hemorrhage. N e itller 
12(R)-HETrE nor 12(S)-HETrE had any effect on th.is reaction 
either at 1-4 h o r at 24 h at doses fOllnd to modu.late PPD-e1icited 
DTH. 
PPD-Elicited Cellular Infiltrates Are Not Modulated by 
12-HETrE Enantiomers Modulation of macroscopic DTH re-
activity by 12-HETrE enantio m ers was not associated with any 
changes in cellular infiltrates at the reaction site . Deep and super-
fic ial dermal cellular infiltra tes were significantly greater in biopsy 
Table I. Lack of Enhancement of PMA-Elicited 




102 ± 1" 
91 ± 2 
Dose (plllol) 
95 ± 1 
97 ± 3 
lOS ± 2 
107 1: 3 
99 ± 3 
84 ± 1 
.. Mean skin rca ction (:!: SEM) rela tive to PMA (100%), n = 6. Skin responsc to 
intr;ldcn llal injection of 'ID 'IllIOI PMA (100 tX,) W:lS 89 ± 1mll,2. 
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Table II. Effect of 12(R)- and 12(S)-HETrE on Cellular Infiltrates in PPD-Elicited DTH Reactions 
Dermal Infiltrates 
Trcfltnl cn t Superficia l (Cells/5 Oil Fie lds) 
PPD 12(R.)-HETrE 12(S)-HETrE Deep Mononuclear Mast 
(500 ng) ( 10- ' plllol) (10 - ' pmol) (QLla litative) Cells Basophils Neutro phils Eosinophils Cells 
0.1 :': 0.1" ·19 :': 3" 0.3 :': 0.2 0.8 :': 0.4 0.2 :': 0.2 1 :': 0.8 
+ 2.4 :': 0.5 95 :': 13 4 :': 2 7 :': 2 0.3 :': 0.3 2 :': 0.8 
+ + 2.4 :': 0.4 86 :': 12 2 :': 2 3 :': 1 0.6 :': 0.4 2 :': 0.7 
+ + 2.8 :': 0.5 105 :': 15 5 :': 2 7 :': 2 0 :': 0 0.4 :': 0.2 
+ + + 1.9 :': 0.4 87 :': 13 3 :': 2 6 :': 3 0.6 :': 0.6 2 :': 0.8 
" Meall q ll aJic<ltivc deep dCfl11 :1 1 infiltrate ( ::!: SEM) . 11 = O. Infiltrate is signifi cantl y g rcn tc r in specimens of PPO-elicited reactio ns th:1I1 in CO il t ro is (I' < 0.05). 
" MC;lIl superfic ial derm al infiltr<lfC cclllllllllhcr per five o il fields (± SEM), 11 ;:;;: 6. Number of monolluclear cells, basophils. and I1cutrophils is signifi can tly g reater ill speci mens 
of PPO-elicited "cacrioll s than in contro ls (p < 0.05) . 
spccimens from PPD-injected skin sites than fi·om PBS-injectcd 
co ntrol sites (Table II). Therc was no qual.itative or quantitativc 
dilfc rcnce in cellul ar infiltrates in skin sitcs £i·om PPD rca ctions and 
skin sitcs fi·om reactions e li cited by PPD in thc presence of 12(R)-, 
12(S)-, or 12(R)- and 12(S)-HETrE. T he modula tory effects of 
12(R)-HETrE on exprcssion ofDTH thus appcal· to be confined to 
the vascular am1 of this inflammatory response. 
DISCUSSION 
Thc present study dcscribes thc clfects of the close ly rela ted 
12-hydroxyeicosanoid derivativcs , 12(R)-HETE, 12(S)-HETE, 
12(R)-I-IETrE, and 12(S)-HETrE on the expression of DTH in 
gu inea pig skin . All are potentially important iJ1 this cell-mcdiatcd 
inflammatory response, as they may bc formed from arachidonic 
acid at cutaneous inflammatory sites . We ha vc found that 12(R)-
HETrE cnhan ccs DTH inflammatory reactions, with a maximal 
50% enhancemcnt at 1-fi1101 doscs and significant enhanccmcnt at 
doses up to 1 pmol. T his cffect was specific for 12(R)-HETrE, as no 
signi ficant enhan ccment of DTH cxpression was observed wi th its 
cnantiomer or with the other 12-hyd roxyeicosa noids testcd. None 
of the 12-hydroxycicosanoids modulated the nonimmunologic 
delayed inflammatory rcaction induccd by PMA. 
Our observations providc additional support for the definition of 
12(R.)-HETrE, a novel eicosa noid produced by the skin , corn ea, 
and neutrophil, as a proinflammatory compound . Previous studi es 
havc described its potcnt biologic activities, including vasodilation 
of rat-tail arterics and rabbit limbal vessels, incrcased capillary 
pcrmca bility, human neutrophil chemotaxis, ncovasculariza tion, 
and cndothelial ccll mitogenesis [21 ,25J.'11 In tbese studi es, 12(R)-
HETrE was maximally cffcctive in mcdiating thcse responses at 10 
pM, corresponding to the 1- fi1101 dose found to bc maximally 
elfective in enh ancing DTI-I reactions, and displayed a bcll-shaped 
dosc-rcsponse curve similar to the one observed in the prcsent 
study. This implicatcs 12(R)-I-IETrE as a potcnti al infl ammatory 
mediator in skin tissucs. 12(R)-HETrE's stereoisomer, 12(5)-
HETrE, and thc rclatcd 12(S)-HETE and 12(R)-I-IETE, do not 
share thesc biologic activities. 
Biosynthesis of 12-HETrE was dcmonstrated initial ly in bovin c 
cornca l cpithelia l microsomes incub:ltcd with arachidonic acid a.nd 
NADPI-[ [21]. T he reaction was lllfccted neither by cyclooxygena sc 
inhibitors (indomcthacin and asp irin) nor by lipoxygen<Jsc i.nhibitors 
(BW775C, NDGA) . T he formation o f 12 (R)-HETrE w as inhibited 
by intcrventions of the cytochrome P450 monoo)l.},gen<lse pathway 
via iJ1hibitors (ca rbon monoxidc, SKF-525A, c1otrimazole) or 
antibodies to cytochromc P450. T his strongly suggests involvement 
of a cytochrome P450 J110nooA},gcnasc in synth esis of this eico-
sa noid [21 ,35J. Furthcr studies havc shown that 12-I-IETE is a 
'II Grillin MO. Davis KL, Dunn MW. Abraham NC. Schwartzman ML: 
Effect of J 2(H .. )-hydroA],c icosatricnoic acid (12(R.) I-IETrE), a co rnca l angio-
genic facto r, 011 ' H-thymidinc incorporation and oncogene expression in 
cornca l and vascu lar cells (abstr). itl llest Ophtha/I11{) / Vis Sci 31 :505, 1990. 
substrate for the synthesis of 12-HETrE in corneal tissues and 
suggested that oxidativc/ketoreductive steps are involved in the 
synthesis [22,36J. Whereas 12(R)-HETE is a cytochrome-P450-
derived metabolite of arachidon.ic acid [37] , 12(S)-HETE is pre-
dominantly a lipoxygen3se metabolite [38]. 
T he production of 12(R)-HETE by skin was shown initially in 
human psoriati c lesions by Woollard [17], who suggested that it 
was generated by a cytochrome P450 1110noox),genase enzym e, a 
systcm known to exist in skiJ1 tissue [39] . The presence of an 
cicosanoid with high performance liquid chromatography retention 
time similar to that of 12-HETrE also was documcnted [40]. More 
recently, human and rat epidermis has becn shown to produce 
12-HETE enantiomers by both lipoxygenase and cyt~chrome P450 
monOOA),genasc pathways, and rat epidermal microsomes have 
been shown to produce 12- HETrE enantiomers by an N ADPH-
dependent mechani sm [1 2,13]. Production of 12-HETrE is not 
limi ted to epidermal cells; for exa mple, porcine neutrophils also can 
generate thcsc eicosanoids from 12-HETE [27]. Thus, the 12-
I-IETrE in skin tissue can orig inate from the epidermis itself, 
infiltrating leukocytes, or both. 
12(R)-HETE is a chemoattractant for neutrophils and mixed 
peripheral blood lymphocytes at high nanomolar concentrations 
[41,42] , an activity thought to be mediated via binding to the 
leukotrienc B" receptor [43] . Our studies show that 12(R)-HETE 
significantly rcduccd DTI-I expression by 25% at 10 pmol, a dosc 
comparable to 100 nM . Paralle l studi es by Godfrey e/ al. ** havc 
shown that leukotriene B" itse lf can produce a concentration-
dependent decrease U1 the DTH reaction. Thus , we hypothesize 
that 12(.R)-l-IETE decreases expression of DTH via interactions 
w ith a leukotri ene B" receptor and through a yet to be determined 
mechanism. In contrast, 10 - 5 to 10' pmol doses of 12(S)-HETE 
had no modulating effect on the DTH inflammatory reaction. This 
is not surprisulg, for although 12(S)-HETE has been shown to 
displ acc 3I-1-leukotriene B4 fi·om its receptor sitc on the rat leuko-
cyte mcmbrane, at least micL"Omolar concentrations are required 
[43]. Although 12(R)-HETrE is a neutrophil chemoattractant [26], 
it does not intcract with thc leukotriene B4 receptor (Schwartzman 
et aI, unpublishcd observations), w hich suggests that its chemotac-
tic activity is not re lated to lcukotriene B" receptor activation. 
Furthel"Jllorc, 12(R)-HETrE had an opposite effect on the DTH 
reaction from leukotriene B", i.e., stimulation rather than inhibi-
tion . Moreover, histologic examination clearly demonstrated that 
the elfect of12(R)-I-IET rE on the de layed erythcma ofPPD-elicited 
DTH reactions was not associated with changcs in cellular infil-
trates. It is possibl e that 12(R)-HETrE's enhancement of the DTH 
reaction is related to its ability to vasodilate blood vessels 
[21,25,28]. That both 12(R)-I-IETrE and 12(R)-I-IETE had no 
•• Godfrey HI'. Zhu Y, Mandy S, Fcng Z-H , Lin H, Wong PY-J(: An 
LTB" receptor antagonist (SC4·1930) blocks LTB" 1I10duia tion o f delayed 
hyperscnsitivity inflammatory reactions in guinea pigs (abstr). F;lSEB J 
6:A1337, 1992 . 
VOL. 104. NO. I JANUARY 1995 
effect w hen injected without stimulus may be due solely to 
insuffi cient doses. However, other expl anations are possible as well. 
For example, it may be that their efFect required priming, i.e., a 
stimulus to ini tiate the inflammatory state. O ne sho uld remember 
that the observed effect of these compo unds may be species- , 
tissue-, and stimulus-specific. C learly, further studies arc needed to 
elucidate the mechanism of action of this novel eicosano id on the 
DTH reaction. 
12(S)-HETrE, the enantiomer of 12(R)-HETrE, has been shown 
to be synthesized by the rat epidermis [1 3]. Altho ugh it produced 
no enhancem ent ofPPD-e licited DTH reactio ns on its own, it was 
able to block the effect of equimoiar doses of 12(R)-HETrE. 
12(S)-HETrE might therefore act as an endogenous antagonisumd 
could be use ful in studying the pro inflammatory actions of 12(R)-
HETrE. 
In summary, enhancem en t of DTH reactions must be added to 
the increasing list of proinflammatory actions of 12(R)-HETrE. 
Tlus and the discovery of its biosynthesis in the epidermis further 
promote this nove l eicosa no id as a potential mediator of inflamma-
tory conditions ill the skin . 
T his II/ork II/as slIpported by Nt/tioll al fllStitllt es oIHealth gmllts E l' 065 / J (i\ll. L.S.) 
nlld CA34141 (H.P.G.). M.S.C. is n recipiellt oInIcl/oll/ship.!i·o", the PIIII,.,IIa-
eeutienl Ma ll/ tIaelllr",.s Associat io/l Fouuriatioll , ii II'. , GNf31 278 (PMA) . 
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